Demand for healthcare still expected to climb


RHB Research said payer pressure is reshaping hospital economics with fewer inpatient admissions, structurally lower revenue intensity, and declining bed occupancy rates.

PETALING JAYA: RHB Research expects demand for private healthcare to remain resilient, underpinned by growth in medical tourism, the rise of non-communicable diseases and an ageing population.

This is despite the soft results from the sector in the recent results season, with payer negotiations and the shift to a daycare model weighing on inpatient growth.

Revenue intensity rose on efficiency gains, while earnings before interest, taxes, depreciation and amortisation (Ebitda) margins held steady, despite the drag from maturing hospitals.

RHB Research, which kept an “overweight” call on the healthcare facilities and services sector said payer pressure is reshaping hospital economics with fewer inpatient admissions, structurally lower revenue intensity, and declining bed occupancy rates.

“Operators that pivot capacity toward daycare, ambulatory, and surgical services, while improving cost efficiency, are best positioned to mitigate these pressures,” the research house noted.

On the sector’s outlook, RHB Research said it believes the ongoing shift in the case mix towards a daycare format could be structurally favourable. Daycare procedures are typically priced at almost half that of inpatient cases, but higher patient turnover, lower running costs, and greater efficiency help offset the gap.

More importantly, the shift frees up inpatient beds, which can then be prioritised for complex surgical cases rather than lower-yield medical cases.

“This reallocation supports sustained improvements in revenue intensity, even as overall inpatient growth moderates.

“Taken together, we see operators well-positioned to adapt to payer-driven changes, with demand resilience underpinned by demographic and structural healthcare trends,” RHB Research said.

KPJ Healthcare Bhd remains the research house’s top pick with a target price of RM3.05. Despite recent share price weakness, it said KPJ still trades at a 7.2% premium to IHH Healthcare Bhd’s forward-rolling enterprise value/Ebitda.

“While we recognise KPJ’s concentration risk as its revenue is predominantly derived from Malaysia, we also maintain our ‘buy’ call on IHH, as it offers a more diversified revenue base,” the research house added.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!

Next In Business News

China stocks rebound from 14-month lows as AI firms unveil buybacks, stellar forecasts
Malaysia data centre market projected to grow 33% CAGR from 2025-2030
Dollar heads for weekly fall as investors gauge AI selloff impact
BNM maintains D-SIB status, capital requirements for Maybank, CIMB, Public Bank
Oil eases, but set for weekly gain on Mideast supply risks
Asian bonds record biggest monthly foreign outflow since March 2020
Taiwan-listed FICG opens manufacturing facility in Johor
Indonesia stocks sink most since 1998 after MSCI flags 'standalone' downgrade
Asia-Pacific urged to ready workers for AI
Budget 2027: RM8bil TVET allocation to boost aviation, automotive sectors

Others Also Read